loadpatents
name:-0.067394018173218
name:-0.045052051544189
name:-0.023927211761475
NATCO PHARMA LIMITED Patent Filings

NATCO PHARMA LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for NATCO PHARMA LIMITED.The latest application filed is for "a process for the preparation of venetoclax and its polymorphs thereof".

Company Profile
27.62.67
  • NATCO PHARMA LIMITED - Hyderabad N/A IN
  • Natco Pharma Limited - Banjara Hills, Hyderabad IN
  • NATCO PHARMA LTD - Hyderabad IN
  • NATCO PHARMA LIMITED - IN IN
  • NATCO PHARMA LIMITED - Banjara Hills IN
  • Natco Pharma Limited - Hyderabad, Andhra Pradesh N/A IN
  • Natco Pharma Limited - Andhra Pradesh IN
  • NATCO PHARMA LIMITED - Hyderabad, Andhura Pradesh IN
  • Natco Pharma Limited - Andra Pradesh IN
  • Natco Pharma Limited - Hyperabad IN
  • Natco Pharma Ltd. - Hyderabad IN
  • Natco Pharma Limited - Natco House, Road No. 2, Banjara Hills Hyderabad IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stable pharmaceutical compositions comprising lenalidomide
Grant 11,452,722 - Satyanarayana , et al. September 27, 2
2022-09-27
A Process For The Preparation Of Venetoclax And Its Polymorphs Thereof
App 20220259204 - SIRIGIREDDY; Balakrishna Reddy ;   et al.
2022-08-18
Process for the preparation of ribociclib succinate and its novel crystalline forms thereof
Grant 11,414,421 - Thiriveedhi , et al. August 16, 2
2022-08-16
Process For The Preparation Of High Pure Eribulin And Its Mesylate Salt
App 20220089607 - DIVYA; Prabhakar ;   et al.
2022-03-24
Improved Process For The Preparation Of Tipiracil Hydrochloride And Intermediates Thereof
App 20220056016 - SAKKANI; Srinivasulu ;   et al.
2022-02-24
An Improved Process For The Preparation Of Sugammadex Sodium And Its Novel Polymorphic Form
App 20210355248 - PRABHAKAR; Vanga ;   et al.
2021-11-18
Process for the preparation of pomalidomide and its purification
Grant 11,111,228 - Konakanchi , et al. September 7, 2
2021-09-07
Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride
Grant 11,091,470 - Muddasani , et al. August 17, 2
2021-08-17
Stable Pharmaceutical Compositions Comprising Lenalidomide
App 20210196698 - SATYANARAYANA; Vattikuti ;   et al.
2021-07-01
An Improved Process For The Preparation Of Cabozantinib And Its Pharmaceutically Acceptable Salts Thereof
App 20210188776 - AMALA; Kompella ;   et al.
2021-06-24
Intermediates for the preparation of eribulin thereof
Grant 11,008,296 - Vipparla , et al. May 18, 2
2021-05-18
An Improved Process For The Preparation Of Ribociclib Succinate And Its Novel Crystalline Forms Thereof
App 20210122754 - THIRIVEEDHI; Arunkumar ;   et al.
2021-04-29
Pharmaceutical compositions of pomalidomide
Grant 10,966,971 - Vattikuti , et al. April 6, 2
2021-04-06
Pharmaceutical Compositions Comprising Ibrutinib
App 20210060019 - SATYANARAYANA; Vattikuti ;   et al.
2021-03-04
Stable Pharmaceutical Compositions Comprising Trifluridine And Tipiracil Hydrochloride
App 20200405741 - RAMA SWAMY CHOWDARY; Tripuraneni ;   et al.
2020-12-31
Process for the preparation of amorphous idelalisib
Grant 10,870,650 - Kompella , et al. December 22, 2
2020-12-22
An Improved Process For The Preparation Of N-(3-ethynylphenyl)-7-methoxy-6-(3- Morpholinopropoxy) Quinazolin -4-amine Dihydrochloride
App 20200331899 - MUDDASANI; Pulla Reddy ;   et al.
2020-10-22
Process for the preparation of dasatinib polymorph
Grant 10,800,771 - Konakanchi , et al. October 13, 2
2020-10-13
Intermediates For The Preparation Of Eribulin Thereof
App 20200299248 - VIPPARLA; Bulli Babi ;   et al.
2020-09-24
Process for the preparation of Ibrutinib
Grant 10,626,117 - Muddasani , et al.
2020-04-21
Modified process for the preparation of Ceritinib and amorphous form of Ceritinib
Grant 10,604,505 - Konakanchi , et al.
2020-03-31
Process For The Preparation Of Amorphous Idelalisib
App 20200095249 - KOMPELLA; Amala ;   et al.
2020-03-26
Pharmaceutical Compositions Of Pomalidomide
App 20200054621 - Vattikuti; Satyanarayana ;   et al.
2020-02-20
An Improved Process For The Preparation Of Regorafenib
App 20190300484 - MUDDASANI; Pulla Reddy ;   et al.
2019-10-03
An Improved Process For The Preparation Of Dasatinib Polymorph
App 20190292177 - KONAKANCHI; Durga Prasad ;   et al.
2019-09-26
Pharmaceutical compositions comprising phenylaminopyrimidine derivative
Grant 10,383,872 - Parvataneni , et al. A
2019-08-20
An Improved Process For The Preparation Of Ibrutinib
App 20190241567 - MUDDASANI; Pulla Reddy ;   et al.
2019-08-08
Process For The Preparation Of Pomalidomide And Its Purification
App 20190233389 - Konakanchi; Durga Prasad ;   et al.
2019-08-01
Pharmaceutical compositions comprising phenylaminopyrimidine derivative
Grant 10350209 -
2019-07-16
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors
App 20190201408 - ADIBHATLA KALI SATYA; Bhujanga rao ;   et al.
2019-07-04
Modified Process For The Preparation Of Ceritinib And Amorphous Form Of Ceritinib
App 20190047983 - Konakanchi; Durga Prasad ;   et al.
2019-02-14
Pharmaceutical Compositions Comprising Phenylaminopyrimidine Derivative
App 20190015412 - PARVATANENI; Durga Maheswari ;   et al.
2019-01-17
7-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugs
Grant 10,106,554 - Konakanchi , et al. October 23, 2
2018-10-23
1H-1,8-naphthyridin-2-ones as anti proliferative compounds
Grant 10,047,088 - Kompella , et al. August 14, 2
2018-08-14
Anhydrous lenalidomide form-I
Grant 10,040,778 - Konakanchi , et al. August 7, 2
2018-08-07
Formulation comprising phenylaminopyrimidine derivative as active agent
Grant 9,895,367 - Parvataneni , et al. February 20, 2
2018-02-20
1h-1,8-naphthyridin-2-ones As Anti Proliferative Compounds
App 20170349588 - KOMPELLA; Amala ;   et al.
2017-12-07
7-(morpholinyl)-2-(n-piperazinyl) Methyl Thieno [2, 3-c] Pyridine Derivatives As Anticancer Drugs
App 20170320891 - KONAKANCHI; Durga Prasad ;   et al.
2017-11-09
1H-1,8-naphthyridin-2ones as anti proliferative compounds
Grant 9,765,072 - Kompella , et al. September 19, 2
2017-09-19
Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
Grant 9,750,700 - Adibhatla , et al. September 5, 2
2017-09-05
1h-1,8-naphthyridin-2ones As Anti Proliferative Compounds
App 20170114057 - KOMPELLA; Amala ;   et al.
2017-04-27
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors
App 20170079983 - ADIBHATLA KALI SATYA; Bhujanga rao ;   et al.
2017-03-23
6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors
Grant 9,481,655 - Adibhatla Kali Satya , et al. November 1, 2
2016-11-01
Process for the preparation of nilotinib
Grant 9,440,959 - Kompella , et al. September 13, 2
2016-09-13
Fermentation process for the production of rapamycin
Grant 9,365,880 - Polavarapu , et al. June 14, 2
2016-06-14
Process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[D][1,3]dioxol-4-yl)acetic acid derivatives
Grant 9,227,948 - Muddasani , et al. January 5, 2
2016-01-05
Anhydrous Lenalidomide Form-i
App 20150353525 - Konakanchi; Durga Prasad ;   et al.
2015-12-10
Anhydrous lenalidomide form-I
Grant 9,108,945 - Konakanchi , et al. August 18, 2
2015-08-18
Process For The Preparation Of Nilotinib
App 20150183762 - Kompella; Amala ;   et al.
2015-07-02
Process for the preparation of Nilotinib
Grant 9,061,028 - Kompella , et al. June 23, 2
2015-06-23
Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives
Grant 9,050,341 - Abidhatla Kali Satya , et al. June 9, 2
2015-06-09
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors
App 20150141421 - ADIBHATLA KALI SATYA; Bhujanga rao ;   et al.
2015-05-21
Process For The Preparation Of 2-substituted-2-(6-(substituted)-7-methylbenzo[d][1,3]dioxol-4-yl)acetic Acid Derivatives
App 20150119587 - Muddasani; Pulla Reddy ;   et al.
2015-04-30
Process for the preparation glatiramer acetate (copolymer-1)
Grant 8,993,722 - Kota , et al. March 31, 2
2015-03-31
Fermentation Process For The Production Of Rapamycin
App 20150079642 - Polavarapu; Baby Rani ;   et al.
2015-03-19
6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors
Grant 8,921,362 - Adibhatla Kali Satya , et al. December 30, 2
2014-12-30
Anhydrous lenalidomide form-I
Grant 8,877,932 - Konakanchi , et al. November 4, 2
2014-11-04
Process for the preparation of lacosamide
Grant 8,759,582 - Muddasani , et al. June 24, 2
2014-06-24
Polymorphs of erlotinib hydrochloride and method of preparation
Grant 8,748,602 - Jyothi Prasad , et al. June 10, 2
2014-06-10
Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]- -benzamide
Grant 8,735,415 - Kompella , et al. May 27, 2
2014-05-27
Anhydrous Lenalidomide Form-i
App 20140121245 - Konakanchi; Durga Prasad ;   et al.
2014-05-01
Process for the preparation of lapatinib and it's pharmaceutically acceptable salts
Grant 8,664,389 - Jyothi Prasad , et al. March 4, 2
2014-03-04
Formulation Comprising Phenylaminopyrimidine Derivative As Active Agent
App 20130338180 - Parvataneni; Durga Maheswari ;   et al.
2013-12-19
Process For The Preparation Of Bosentan Monohydrate
App 20130245259 - Kompella; Amala Kishan ;   et al.
2013-09-19
Process For The Preparation Of Nilotinib
App 20130210847 - Kompella; Amala ;   et al.
2013-08-15
Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt
Grant 8,501,962 - Konduri , et al. August 6, 2
2013-08-06
Process To Prepare S-2-hydroxy-3-methoxy-3,3-diphenyl Propionic Acid
App 20130184490 - Kompella; Amala ;   et al.
2013-07-18
Process To Prepare Ethyl 4-methyl-2-(4-(2-methylpropyloxy)-3-cyanophenyl)-5-thiazolecarboxylate
App 20130172571 - Kompella; Amala ;   et al.
2013-07-04
Polymorphic forms of Sunitinib base
Grant 8,466,190 - Konduri , et al. June 18, 2
2013-06-18
Novel Polymorphs Of Erlotinib Hydrochloride And Method Of Preparation
App 20130131341 - JYOTHI PRASAD; Ramanadham ;   et al.
2013-05-23
Process For The Preparation Of Highly Pure Ambrisentan
App 20130060031 - Kompella; Amala ;   et al.
2013-03-07
Anhydrous Lenalidomide Form-i
App 20130059889 - Konakanchi; Durga Prasad ;   et al.
2013-03-07
Process For The Preparation Of Highly Pure Crystalline Imatinib Base
App 20130060030 - Kompella; Amalia ;   et al.
2013-03-07
Process For The Preparation Of Lacosamide
App 20130035508 - Muddasani; Pulla Reddy ;   et al.
2013-02-07
Polymorphs of erlotinib hydrochloride and method of preparation
Grant 8,349,855 - Jyothi Prasad , et al. January 8, 2
2013-01-08
Imatinib Mesylate Oral Pharmaceutical Composition And Process For Preparation Thereof
App 20120329810 - Adibhatla; Kali Satya Bhujanga Rao ;   et al.
2012-12-27
Process For The Preparation Of Lapatinib And Its Pharmaceutically Acceptable Salts
App 20120245351 - Jyothi Prasad; Ramanadham ;   et al.
2012-09-27
Novel 4-(tetrazol-5-yl)-quinazoline Derivatives As Anti Cancer Agent
App 20120172380 - Konakanchi; Durga prasad ;   et al.
2012-07-05
Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
Grant 8,183,253 - Kompella , et al. May 22, 2
2012-05-22
Acid Addition Salts Of (3,5-bis Trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]- -benzamide
App 20120077833 - KOMPELLA; Amala Kishan ;   et al.
2012-03-29
6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders
Grant 8,143,250 - Jyothi Prasad , et al. March 27, 2
2012-03-27
Process For The Preparation Of Lanthanum Carbonate Dihydrate
App 20120058200 - Muddasani; Pulla Reddy ;   et al.
2012-03-08
4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent
Grant 8,080,558 - Konakanchi , et al. December 20, 2
2011-12-20
Crystal form of phenylamino pyrimidine derivatives
Grant 8,067,422 - Kompella , et al. November 29, 2
2011-11-29
Polymorphic form of imatinib mesylate and a process for its preparation
Grant 8,048,883 - Amala , et al. November 1, 2
2011-11-01
Novel Process For The Preparation Of Lapatinib And Its Pharmaceutically Acceptable Salts
App 20110263852 - Jyothi Prasad; Ramanadham ;   et al.
2011-10-27
Acid Addition Salts Of (3,5-bis Trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]- -benzamide
App 20110190328 - Kompella; Amala Kishan ;   et al.
2011-08-04
Process for the prepartion of erlotinib
Grant 7,960,545 - Jyothi Prasad , et al. June 14, 2
2011-06-14
Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylami- no)-phenyl]-benzamide
Grant 7,939,541 - Kompella , et al. May 10, 2
2011-05-10
Process For The Preparation Of High Purity Sunitinib And Its Pharmaceutically Acceptable Salt
App 20110092717 - Konduri; Srinivasa Krishna Murthy ;   et al.
2011-04-21
Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
Grant 7,910,598 - Kompella , et al. March 22, 2
2011-03-22
6-7,dialkoxy Quinazoline Derivatives Useful For Treatment Of Cancer Related Disorders
App 20110039844 - Jyothi Prasad; Ramanadham ;   et al.
2011-02-17
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors
App 20110034459 - ADIBHATLA KALI SATYA; Bhujanga rao ;   et al.
2011-02-10
Methods Of Treating Drug Resistant And Other Tumors By Administering 6,7-dialkoxy Quinazoline Derivatives
App 20110028473 - ADIBHATLA KALI SATYA; Bhujanga rao ;   et al.
2011-02-03
Process For The Preparation Glatiramer Acetate (copolymer-1)
App 20100324265 - Kota; Satyanarayana ;   et al.
2010-12-23
Novel Pyrazolo [3, 4 -d] Pyrimidine Derivatives As Anti-cancer Agents
App 20100298351 - Konakanchi; Durga Prasad ;   et al.
2010-11-25
Novel Polymorphs Of Erlotinib Hydrochloride And Method Of Preparation
App 20100261738 - Jyothi Prasad; Ramanadham ;   et al.
2010-10-14
Novel 4-(tetrazol-5-yl)-quinazoline Derivatives As Anti Cancer Agent
App 20100261740 - Konkanchi; Durga Prasad ;   et al.
2010-10-14
Novel Process For The Prepartion Of Erlotinib
App 20090306377 - Jyothi Prasad; Ramanadham ;   et al.
2009-12-10
Crystal Form Of Phenylamino Pyrimidine Derivatives
App 20090227611 - Kompella; Amala kishan ;   et al.
2009-09-10
Phenylaminopyrimidine Derivatives As Inhibitors Of Bcr-abl Kinase
App 20080306100 - KOMPELLA; Amala Kishan ;   et al.
2008-12-11
Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation
App 20080255138 - Amala; Kompella ;   et al.
2008-10-16
Intermediates And A Process Employing The Intermediates For The Preparation Of (3-trifluoromethylsulfonyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylami- No)-phenyl]-benzamide
App 20080249121 - Kompella; Amala Kishan ;   et al.
2008-10-09
Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
App 20070232633 - Kompella; Amala kishan ;   et al.
2007-10-04
Enteric Soft Gelatin Capsule Containing Esomerpazole And Method Of Preparation
App 20070196463 - Podili; Khadgapathi ;   et al.
2007-08-23
Pharmaceutical composition and a process for its preparation
App 20050095285 - Rao, Pavuluri Venkateswara ;   et al.
2005-05-05
Rapid acting freeze dried oral pharmaceutical composition for treating migraine
App 20050084530 - Rao, Pavuluri Venkateswara ;   et al.
2005-04-21
Company Registrations
NCAGE Code2174YNATCO PHARMA LTD
NCAGE CodeSKZ04NATCO PHARMA LTD
CAGE CodeSKZ04NATCO PHARMA LTD NATCO RESEARCH CENTRE
CAGE Code2174YNATCO PHARMA LTD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed